FREE SHIPPING ON ORDERS OVER $150

kras mutation and glutathion glynac Metabolic networks in mutant KRAS-driven tumours: tissue specificities the microenvironment Uncovering new therapeutic targets for

$20.21

Quantity
- +
Description

Romagnani P, Remuzzi G, Glassock R, Levin A, Jager KJ, Tonelli M

kras mutation and glutathion glynac Metabolic networks in mutant KRAS-driven tumours: tissue specificities the microenvironment Uncovering new therapeutic targets for

iTIND (Temporarily Implanted Nitinol Device) The iTIND is a minimally invasive option that involves inserting a small probe into the prostate and using radiofrequency energy to heat and destroy excess tissue

kras mutation and glutathion glynac Metabolic networks in mutant KRAS-driven tumours: tissue specificities the microenvironment Uncovering new therapeutic targets for

19mm 3/4

kras mutation and glutathion glynac Metabolic networks in mutant KRAS-driven tumours: tissue specificities the microenvironment Uncovering new therapeutic targets for

3.4/5 5 Ratings Response Rate 71% Ask for more details from the seller Contact Supplier 500/Boxes Get Latest Price Send Inquiry

kras mutation and glutathion glynac Metabolic networks in mutant KRAS-driven tumours: tissue specificities the microenvironment Uncovering new therapeutic targets for

SYN is a trademark of DSM, Matrixyl synthe'6 and Matrixyl 3000 are trademarks of Sederma Inc., and ARGIRELOX is a trademark of Lipotec S.A.U

kras mutation and glutathion glynac Metabolic networks in mutant KRAS-driven tumours: tissue specificities the microenvironment Uncovering new therapeutic targets for

You may also like

PT-141

US$ 25.89

4.9 (29 reviews)

recommand products